ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Asia

Pakistan: NEPRA approves increase of PKR 1.15 per unit hike in electricity price

Pakistan's National Electric Power Regulatory Authority (NEPRA) has approved a Pakistani Rupees (PKR) 1.15 per unit increase in electricity prices

ANI Dec 20, 2023 20:32 IST googleads

Representative Image

Islamabad [Pakistan], December 20 (ANI): Pakistan's National Electric Power Regulatory Authority (NEPRA) has approved a Pakistani Rupees (PKR) 1.15 per unit increase in electricity prices, Pakistan-based Dawn News reported.
NEPRA has decided to increase the electricity price for the first quarter of 2023. It has sent the decision to increase the price of electricity to Pakistan's federal government for notification, according to Dawn News reported.
The NEPRA has taken the decision that additional collections will be made during January-March 2024. The rise in electricity prices will place an additional burden of PKR 22 million 30 crore on electricity consumers, according to Dawn News report.
Earlier this month, Pakistan's National Electric Power Regulatory Authority (NEPRA) approved a Pakistani rupee (PKR) 3.07 per unit increase in electricity prices, applicable to all power distribution companies, Geo News reported.
In a notification, the regulator said: "The [...] adjustment shall be shown separately in the consumers' bills on the basis of units billed to the consumers in the month of October 2023 in the billing month of December 2023.
"NEPRA has notified the increase on account of variations in fuel charges, the notification mentioned, in a move that will impact millions of the electricity distribution companies' (Discos) inflation-weary consumers, as per Geo News report.
The increase will not apply to Karachi-Electric (KE) consumers. Furthermore, electric vehicle charging stations (EVCs) and lifeline consumers will also not be impacted by the increase, according to the notification.
In Pakistan, power prices are persistently on the rise as the cash-strapped nation tries to curb its circular debt and meet the conditions of the International Monetary Fund (IMF). (ANI)

Get the App

What to Read Next

Europe

Blasphemy laws in Pakistan target religious minorities: GHRD

Blasphemy laws in Pakistan target religious minorities: GHRD

At the 61st session of the United Nations Human Rights Council, the organisation Global Human Rights Defence (GHRD) raised concerns over the continued misuse of blasphemy laws in Pakistan and their impact on religious minorities.

Read More
US

Brazil’s Silveira rules out fuel shortages, slams speculation

Brazil’s Silveira rules out fuel shortages, slams speculation

Speaking to journalists, Silveira said the country's fuel supply remains stable and the government is closely monitoring developments in the international oil market as well as domestic price movements.

Read More
Asia

MEA rejects Pakistan’s statement on India-Canada deal

MEA rejects Pakistan’s statement on India-Canada deal

"We reject this statement made by Pakistan on the matter. India's credentials regarding non-proliferation are impeccable and well recognised by the global community. A country with a well-documented history of clandestine nuclear proliferation can hardly preach the virtues of export controls and proliferation risks. Such ludicrous statements are nothing more than an attempt by Pakistan to distract from its own abysmal record," he said.

Read More
Asia

India rejects Pakistan's "baseless allegations"

India rejects Pakistan's

India on Thursday rejected Pakistan's allegations of aggravating skirmishes with Afghanistan, calling them "baseless" and accusing Pakistan of blaming others for its own misdeeds.

Read More
Asia

Policy delays leave Pakistan short of critical medicines

Policy delays leave Pakistan short of critical medicines

Pakistan faces a severe shortage of life-saving medicines, including cancer drugs and vaccines, due to government delays in notifying official prices. While global supply remains stable, regulatory hurdles have stalled legal imports, raising concerns over patient survival and the potential rise of unregulated, counterfeit medicines.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.